Tricia A. McNeill

Her practice includes secured and unsecured credit facilities, leveraged financings, asset based loans, mezzanine and second lien lending arrangements, refinancings and restructurings, private equity acquisition financings, and other complex financing transactions. Tricia is experienced across a diverse range of industry sectors, including manufacturing, pharmaceuticals, health care, financial services, and technology.

• Borrower and Private Equity Sponsor Representations

• Represented a public pharmaceutical company focused on developing and commercializing new medicines for pain management in connection with a credit facility, which consisted of a $650 million term loan.

• Represented a Princeton, New Jersey-based public biotechnology company focused on novel medicines for rare diseases in connection with a $430 million financing.

• Represented a building materials company in connection with the financing of the acquisition of a leading producer of aggregates and cement, which included a $3.95 billion term loan facility and a $1.50 billion revolving loan facility, as well as a Rule 144A offering of $3.95 billion aggregate principal amount of senior secured notes and $1.40 billion aggregate senior notes.

• Represented a public company in connection with amendments to its revolving credit and term loan facilities and notes, related restructuring matters, and the collateralizing of such debt in various cross-border jurisdictions and the United States. The company had (i) two syndicated revolving facilities (total aggregate commitments of $2.15 billion) and a syndicated term loan (aggregate commitments of $500 million), (ii) two note purchase agreements with an aggregate of $1 billion in notes issued thereunder in favor of a variety of institutional investors, and (iii) approximately $1.7 billion in letter of credit debt outstanding under bilateral letter of credit agreements with a variety of financial institutions.

• Represented a leading private equity investment firm in the energy industry in connection with its financing to fund a leveraged acquisition of a natural gas and dual-fuel electric generating power plant. The financing consisted of a $200 million term loan facility and a $40 million revolving credit facility.

• Represented a Greenwich, Connecticut-based private equity investment firm in connection with financing used to fund several leveraged acquisitions, including the acquisition of a commercial janitorial company. The financing consisted of a $420 million senior secured term loan, a $150 million senior secured delayed draw term loan, and a $50 million senior secured first-out revolving credit facility.

• Represented a Charlotte, North Carolina-based middle-market private equity firm in connection with financing used to fund several leveraged acquisitions, including the leveraged acquisition and recapitalization of a special logistics solutions provider and medical supply distributor, which consisted of a $105 million senior secured credit facility and a $30 million unsecured term loan.

• Represented a subprime consumer lender in connection with a $450 million special purchase structured warehouse facility and a $50 million over-advance facility.

• Lender Representations

• Represented a leading national bank as agent in connection with a $70 million senior secured credit facility used to finance a private equity firm's leveraged acquisition.

• Represented a direct lender in connection with an extension of $130 million in senior secured term loans to a portfolio company of a private equity firm and a leading management services organization serving ambulatory surgery centers.

• Represented a junior capital provider in connection with a $25 million secured second lien term loan facility. Proceeds were used to finance the leveraged acquisition by a middle-market private equity firm of a provider of comprehensive home health and hospice care services.

• Represented a reinsurance company in connection with its purchase, alongside other purchasers, of $51.5 million senior subordinated notes from a portfolio company of a private equity firm that provides consulting, engineering, medical, and environmental services in support of national defense and homeland security matters. The proceeds were used to fund a dividend.

• Represented a middle-market private investment firm regulated by the U.S. Small Business Administration and a reinsurance company in their purchase of $26 million in senior subordinated notes used to finance a private equity firm's leveraged acquisition of a leading designer and manufacturer of precision parts.

• Represented a middle-market private investment firm regulated by the U.S. Small Business Administration in connection with its purchase of $11.5 million in senior secured notes.

• Included in Best Lawyers: Ones to Watch in America™ for Banking and Finance Law, Corporate Law, Leveraged Buyouts, and Private Equity Law (2023 – 2025)
• Recipient – "Top Lawyers Under 40 Award," Hispanic National Bar Association (2022)
• Member – Hispanic National Bar Association
  • President – Region VI (2020 – 2022)
  • Deputy President – Region VI (2016 – 2018)
  • Member – Young Lawyers Division, Region VI (2015 – 2016)
• Judicial Intern – Justice Cheri Beasley, North Carolina Supreme Court (2014)

• "Grandparents Act As 'National Guard' of Their Families – Always Eager and Ready to Respond When in Need: A Call for Expansion of Grandparent Visitation Rights in North Carolina," 37 North Carolina Central Law Review 68 (January 2014)

• Moderator – "Annual M&A South Debt Market Update," ACG Atlanta M&A South (February 2025)
• Moderator – "Navigating the Future, Opportunities and Challenges of Private Credit," 100 Women in Finance (November 2024)
• Moderator – "Trends in Deal Making," ACG Southeast Region Women's Forum (October 2024)
• Speaker – "Standing on Business: Defending Your Exit in a Leveraged Sale Transaction," Collective 54 (May 2024)

• Baker Donelson Grows Financial Services Team in Raleigh with Addition of Tricia McNeill (August 5, 2025)